Literature DB >> 12543725

A stepwise model of the development of lymphatic vasculature.

Guillermom Oliver1, Natasha Harvey.   

Abstract

Although lymphedema was first described more than a century ago, little progress has been made in understanding the mechanisms that cause it. Investigation of the normal development of the lymphatic system has been hindered by the lack of known lymphatic-specific markers. In 1902, F. Sabin proposed the most widely accepted theory about the origin of the lymphatic vasculature. This model proposed that isolated primitive lymph sacs bud from the endothelium of veins during early development; from these primary lymph sacs, the peripheral lymphatic system spreads by endothelial sprouting into tissues where local capillaries form. In 1999, we identified the homeobox gene Prox1 as the first specific marker of lymphatic endothelial cells. Functional inactivation of Prox1 in mice demonstrated that lymphangiogenesis requires the activity of this gene in a subpopulation of endothelial cells in embryonic veins. Prox1 promotes the development of the lymphatic vasculature by determining the final lymphatic fate of budding venous endothelial cells. On the basis of our findings, we propose a stepwise model of lymphangiogenesis in which lymphatic vasculature development is initiated by the specific expression of Prox1 in a subpopulation of vascular endothelial cells that subsequently adopt a lymphatic vasculature phenotype.

Entities:  

Mesh:

Year:  2002        PMID: 12543725     DOI: 10.1111/j.1749-6632.2002.tb04876.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves.

Authors:  R Sathish Srinivasan; Guillermo Oliver
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

Review 2.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 3.  Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell.

Authors:  Guillermo Oliver; R Sathish Srinivasan
Journal:  Development       Date:  2010-02       Impact factor: 6.868

4.  Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.

Authors:  Cara C Bertozzi; Alec A Schmaier; Patricia Mericko; Paul R Hess; Zhiying Zou; Mei Chen; Chiu-Yu Chen; Bin Xu; Min-min Lu; Diane Zhou; Eric Sebzda; Matthew T Santore; Demetri J Merianos; Matthias Stadtfeld; Alan W Flake; Thomas Graf; Radek Skoda; Jonathan S Maltzman; Gary A Koretzky; Mark L Kahn
Journal:  Blood       Date:  2010-04-02       Impact factor: 22.113

5.  Dosage-dependent requirement for mouse Vezf1 in vascular system development.

Authors:  Frank Kuhnert; Luisa Campagnolo; Jing-Wei Xiong; Derek Lemons; Michael J Fitch; Zhongmin Zou; William B Kiosses; Humphrey Gardner; Heidi Stuhlmann
Journal:  Dev Biol       Date:  2005-07-01       Impact factor: 3.582

Review 6.  Lymphatic fate specification: an ERK-controlled transcriptional program.

Authors:  Pengchun Yu; Joe K Tung; Michael Simons
Journal:  Microvasc Res       Date:  2014-08-15       Impact factor: 3.514

7.  Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.

Authors:  Patrick A Carroll; Elizabeth Brazeau; Michael Lagunoff
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

8.  Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.

Authors:  Aino Murtomaki; Minji K Uh; Yun K Choi; Christopher Kitajewski; Valeriya Borisenko; Jan Kitajewski; Carrie J Shawber
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

9.  Nitric oxide permits hypoxia-induced lymphatic perfusion by controlling arterial-lymphatic conduits in zebrafish and glass catfish.

Authors:  Lasse Dahl Ejby Jensen; Renhai Cao; Eva-Maria Hedlund; Iris Söll; Jon O Lundberg; Giselbert Hauptmann; John Fleng Steffensen; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

10.  Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Kimberley D Gutierrez; Valerie A Morris; David Wu; Serge Barcy; Michael Lagunoff
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.